Impact of azithromycin treatment on macrophage gene expression in subjects with cystic fibrosis. - Wikidata - wikimedia - TriplyDB

Impact of azithromycin treatment on macrophage gene expression in subjects with cystic fibrosis.

Impact of azithromycin treatment on macrophage gene expression in subjects with cystic fibrosis.

http://www.wikidata.org/entity/Q35223657

about

Azithromycin drives alternative macrophage activation and improves recovery and tissue sparing in contusion spinal cord injury A comprehensive review of glycosylated bacterial natural products.Predictive screening of M1 and M2 macrophages reveals the immunomodulatory effectiveness of post spinal cord injury azithromycin treatment Role of IRE1α/XBP-1 in Cystic Fibrosis Airway Inflammation.Cystic Fibrosis Lung Immunity: The Role of the Macrophage Post-ischemic treatment with azithromycin protects ganglion cells against retinal ischemia/reperfusion injury in the rat.Effects of pre-transplant azithromycin administration on kidney graft function: study protocol for a double-blind randomized clinical trial.Azithromycin promotes alternatively activated macrophage phenotype in systematic lupus erythematosus via PI3K/Akt signaling pathway

P2860

Q27303481-6D60B7BF-ABD2-4246-B092-B2D7A829F9BA Q36029831-C89A969E-4DB7-4F28-9231-280A16282C34 Q37563331-C1E54458-7F9F-4F63-88D2-6B5A2709F211 Q37631563-621FF3E7-C122-41D2-BF61-DDFF437B73B5 Q38874414-0FCC7705-3CC4-4A15-B42C-C46B1626EFA2 Q47119067-0911082D-8DA1-4723-BBE8-8C961B29B556 Q55487726-856C880D-99E2-44D0-BA0F-4586D9584833 Q57801756-F17BD3AD-13EA-4DC0-99A3-54B6FA4CE00C

P2860

Impact of azithromycin treatment on macrophage gene expression in subjects with cystic fibrosis.

http://www.wikidata.org/entity/Q35223657

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Impact of azithromycin treatme ...... subjects with cystic fibrosis.

@ast

Impact of azithromycin treatme ...... subjects with cystic fibrosis.

@en

type

label

Impact of azithromycin treatme ...... subjects with cystic fibrosis.

@ast

Impact of azithromycin treatme ...... subjects with cystic fibrosis.

@en

prefLabel

Impact of azithromycin treatme ...... subjects with cystic fibrosis.

@ast

Impact of azithromycin treatme ...... subjects with cystic fibrosis.

@en

P1433

Q35223657-D2A2F569-B6EA-4A6E-9FE3-CD9A045AC904

P1476

Q35223657-798BC458-175D-4B6B-9B1E-E8D7EC0C4FBD

P2093

Q35223657-2D6DF5FC-8FDD-47E6-B005-AF49294A7371

Q35223657-42670E7A-E592-4C75-815E-D81C530D0AE1

Q35223657-43D0E3A6-E69D-4CF7-ADC8-5AF0D6245686

Q35223657-5BB5A2D2-5B3D-4DFA-B97C-83ACC2D5C2CC

Q35223657-5CD0A343-B5FC-4A6D-8BE4-0A3AC3522AEA

Q35223657-C067D7AF-AE18-42E6-B159-D59F2C243DDF

Q35223657-D5FFCFE8-B289-44E6-9201-934F116BE243

Q35223657-EB079581-2F0A-47E6-A382-3E717C3E9675

Q35223657-F42B013F-4434-41F5-B511-BF83386341A2

P2860

Q35223657-0224AAF0-167B-4FD4-A5B0-36E1F0936BB5

Q35223657-074F4685-D7D7-4F5F-A794-A5A3475F1B60

Q35223657-0D534F8F-316F-432A-8512-4D28875D3CD2

Q35223657-0DFCF653-7287-4F03-AD36-BB3EA17BFE08

Q35223657-0E20F884-E2B3-403E-ADED-CFCC1CD0AD9B

Q35223657-236F6B9F-85F4-4216-ADF7-C9191620BE7F

Q35223657-326E56C9-3644-46D6-8A7B-57EAFD707B4E

Q35223657-3544EDA2-2D0C-4AA0-A5BB-5E9075C56607

Q35223657-39B3E4CC-A7AF-492C-A3D5-0204BD00485B

Q35223657-3E575CAC-514D-4DF5-9512-D61C079D0FD3

P304

Q35223657-FD5524E7-1F54-400A-B84F-3813143D76B0

P31

Q35223657-BD14B338-2B6B-4F84-A754-6574EED1D8CC

P356

Q35223657-D29540CB-35E4-4AD1-A3CE-56418631883A

P433

Q35223657-6829DD18-AA19-4B1D-AE71-F343F39CC0F1

P478

Q35223657-FFC93D2A-7AC3-4011-B61B-E1EC19DBB9D9

P577

Q35223657-E2312C32-3ABC-42BC-9F9A-53113F1B1AD2

P698

Q35223657-6C060546-4E12-4370-B9B3-1E661C08EB54

P921

Q35223657-0434AEB7-213E-4729-B639-6B8A68876BB0

Q35223657-B8FC2E56-163E-4B9E-B9B0-43A917640BE3

Q35223657-DDA9DECF-268F-4D7F-83D4-18FFE2E54A7E

P932

Q35223657-17B9FB87-D94F-4E03-A2F9-8BF0A630A783

P356

J.JCF.2013.08.007

P1433

Journal of Cystic Fibrosis

P1476

Impact of azithromycin treatme ...... subjects with cystic fibrosis.

@en

P2093

Brian S Murphy

http://www.w3.org/2001/XMLSchema#string

David J Feola

http://www.w3.org/2001/XMLSchema#string

Don Hayes

http://www.w3.org/2001/XMLSchema#string

Heather M Bush

http://www.w3.org/2001/XMLSchema#string

Jamshed F Kanga

http://www.w3.org/2001/XMLSchema#string

Michael I Anstead

http://www.w3.org/2001/XMLSchema#string

Robert J Kuhn

http://www.w3.org/2001/XMLSchema#string

Susan E Birket

http://www.w3.org/2001/XMLSchema#string

Theodore J Cory

http://www.w3.org/2001/XMLSchema#string

P2860

Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression

The chemokine system in diverse forms of macrophage activation and polarization

The phenotype of murine wound macrophages.

Regulation of nitric oxide production by arginine metabolic enzymes.

Latent-TGF-beta: an overview.

Clinical significance of microbial infection and adaptation in cystic fibrosis.

Requirement for inducible nitric oxide synthase in chronic allergen exposure-induced pulmonary fibrosis but not inflammation.

Plasma TGF-β₁ in pediatric cystic fibrosis: potential biomarker of lung disease and response to therapy.

Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

Pathophysiology and management of pulmonary infections in cystic fibrosis.

P304

164-171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JCF.2013.08.007

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24018177

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

P932

4376357

http://www.w3.org/2001/XMLSchema#string